[VIEW] agent=Pharmacy Clinical Lead (Anticoagulation Services) | scenario_id=120 | rounds=20

--- Round 0 ---
[R0.1] Risk & Compliance Officer (speak, public): To move forward with the approval process, I need more clarity on the clinical effectiveness and operational scale of the proposed telehealth anticoagulation service. Additionally, could we discuss the current funding and incentive structures that will support its sustainability?
[R0.2] Pharmacy Clinical Lead (Anticoagulation Services) (speak, public): To address your concerns, I can share that in our pilot outcomes with two clinics, we managed to improve the time in therapeutic range from 52% to 68% for 180 patients. Additionally, we estimate an enrollment funnel of 640 eligible patients per quarter, with a pilot enrollment rate of 28%. For the funding and incentive structures, I believe we need to discuss the broader reimbursement model and ensure it aligns with our operational capacity. Let's explore this further together.
[R0.3] Payer Contracting & Finance Manager (speak, public): To clarify the financial sustainability aspect, we need to consider the reimbursement model. Currently, we're looking at a per-episode reimbursement of $62 with a projected volume of 9,600 episodes per year. This needs to align with our operational capacity and the expected demand. Additionally, could you provide details on the staffing intensity required for this program?

--- Round 1 ---
[R1.1] Risk & Compliance Officer (speak, public): Thank you for the insights on clinical effectiveness and financial sustainability. To ensure we can effectively manage high-risk clinical situations, could you share how we plan to operationalize these scenarios? Additionally, are there any external deal constraints we should be aware of that might impact our compliance readiness?
[R1.2] Pharmacy Clinical Lead (Anticoagulation Services) (speak, private to=Risk & Compliance Officer,Payer Contracting & Finance Manager): To ensure we can manage high-risk clinical situations effectively, I propose implementing a protocol that includes same-day clinician outreach for critical INR thresholds. This will help us maintain patient safety and compliance. Additionally, regarding external deal constraints, we should conduct a thorough review to identify any potential issues that could affect our operational capacity or compliance readiness. Let's work together to address these aspects further.
[R1.3] Payer Contracting & Finance Manager (speak, private to=Risk & Compliance Officer,Pharmacy Clinical Lead (Anticoagulation Services)): Regarding the expected demand for the program, we estimate an enrollment funnel of 640 eligible patients per quarter with a pilot enrollment rate of 28%. Additionally, could you confirm the legal/vendor terms to ensure we won’t face operational delays? This information is crucial for our financial analysis.

--- Round 2 ---
[R2.1] Risk & Compliance Officer (leave, public): 
[R2.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R2.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 3 ---
[R3.1] Risk & Compliance Officer (leave, public): 
[R3.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R3.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 4 ---
[R4.1] Risk & Compliance Officer (leave, public): 
[R4.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R4.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 5 ---
[R5.1] Risk & Compliance Officer (leave, public): 
[R5.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R5.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 6 ---
[R6.1] Risk & Compliance Officer (leave, public): 
[R6.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R6.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 7 ---
[R7.1] Risk & Compliance Officer (leave, public): 
[R7.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R7.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 8 ---
[R8.1] Risk & Compliance Officer (leave, public): 
[R8.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R8.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 9 ---
[R9.1] Risk & Compliance Officer (leave, public): 
[R9.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R9.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 10 ---
[R10.1] Risk & Compliance Officer (leave, public): 
[R10.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R10.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 11 ---
[R11.1] Risk & Compliance Officer (leave, public): 
[R11.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R11.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 12 ---
[R12.1] Risk & Compliance Officer (leave, public): 
[R12.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R12.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 13 ---
[R13.1] Risk & Compliance Officer (leave, public): 
[R13.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R13.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 14 ---
[R14.1] Risk & Compliance Officer (leave, public): 
[R14.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R14.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 15 ---
[R15.1] Risk & Compliance Officer (leave, public): 
[R15.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R15.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 16 ---
[R16.1] Risk & Compliance Officer (leave, public): 
[R16.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R16.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 17 ---
[R17.1] Risk & Compliance Officer (leave, public): 
[R17.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R17.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 18 ---
[R18.1] Risk & Compliance Officer (leave, public): 
[R18.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R18.3] Payer Contracting & Finance Manager (leave, public): 

--- Round 19 ---
[R19.1] Risk & Compliance Officer (leave, public): 
[R19.2] Pharmacy Clinical Lead (Anticoagulation Services) (leave, public): 
[R19.3] Payer Contracting & Finance Manager (leave, public): 

